Clinical Trial Update: Study of TNFR:Fc (Enbrel) in the Treatment of Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of etanercept (Enbrel) for asthma has completed, reporting results from the NHLBI-sponsored study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Asthma | Phase 2 | Status: COMPLETED